Title of article :
Post-transplantation diabetes mellitus after kidney transplantation and its related factors in Iranian patients: a retrospective single-center study
Author/Authors :
Ramezanzadeh, Elham Razi Clinical Research Development Center - School of Medicine - Razi hospital - Guilan University of Medical Sciences, Rasht, Iran , Tirbakhsh, Azin Razi Clinical Research Development Center - School of Medicine - Razi hospital - Guilan University of Medical Sciences, Rasht, Iran , Monfared, Ali Razi Clinical Research Development Center - School of Medicine - Razi hospital - Guilan University of Medical Sciences, Rasht, Iran , Khosravi, Masoud Razi Clinical Research Development Center - School of Medicine - Razi hospital - Guilan University of Medical Sciences, Rasht, Iran , Lebadi, Mohammadkazem Razi Clinical Research Development Center - School of Medicine - Razi hospital - Guilan University of Medical Sciences, Rasht, Iran , Motamed, Behrang Razi Clinical Research Development Center - School of Medicine - Razi hospital - Guilan University of Medical Sciences, Rasht, Iran , Mokhtari, Gholamreza Razi Clinical Research Development Center - School of Medicine - Razi hospital - Guilan University of Medical Sciences, Rasht, Iran , Kazemnezhad Leyli, Ehsan Razi Clinical Research Development Center - School of Medicine - Razi hospital - Guilan University of Medical Sciences, Rasht, Iran
Abstract :
Introduction: Post-transplantation diabetes mellitus (PTDM) is a metabolic complication
following transplantation, which is associated with cardiovascular disease and leads to increased
post-ttransplantation morbidity and mortality.
Objectives: To identify the incidence of PTDM and its risk factors in kidney recipients at a
single-center in Iran.
Patients and Methods: This retrospective study was conducted on 379 kidney recipients with
a negative history of diabetes mellitus who underwent transplant before January 2017. PTDM
was defined according to the diagnostic criteria of the American Diabetes Association (ADA)
and the World Health Organization (WHO). Data on demographic, clinical characteristics
and laboratory parameters were collected. Kaplan-Mayer analysis was used to evaluate the
cumulative incidence of PTDM. The association between risk factors and PTDM incidence
was identified with stepwise Cox regression.
Results: The cumulative incidence of PTDM during a 24-month follow-up was 30.1% (95%
CI: 25.6-34.8). By univariate analysis, modifiable or non-modifiable risk factors for PTDM
development included recipient age, body mass index (BMI), marital status, family history
of diabetes, smoking, type of transplant, hepatitis C virus (HCV), cytomegalovirus (CMV),
transplant rejection, TG, tacrolimus, cyclosporine and beta blocker. In this study, family
history of diabetes, type of transplant, HCV, CMV, TG, tacrolimus, and beta blocker were
predictors of development of PTDM in Cox proportional hazard models.
Conclusion: The incidence of PTDM was high. Identification of risk factors determines
appropriate strategies for PTDM incidence risk reduction.
Keywords :
Ciclosporin , Immunosuppression , Post-transplantation diabetes mellitus , Renal transplantation , Tacrolimus
Journal title :
Journal of Renal Injury Prevention